DK3337502T3
(da )
2020-09-14
Stabil anti-ifnar1-formulering
IL250363A0
(en )
2017-03-30
Stable formulation of anti-il-4r-alpha antibody
DK3140008T3
(da )
2019-06-24
Hurtigtvirkende insulinsammensætninger
BR112016015706A2
(pt )
2017-08-08
composto, uso do mesmo e composição farmacêutica
DK3143047T3
(da )
2022-10-17
Belimumab-formulering
DK3182962T3
(da )
2023-09-18
Compositions and uses of amidine derivatives
DK3494962T3
(da )
2021-06-21
Flydende inhalationsformulering omfattende RPL554
DK3139904T3
(da )
2021-03-29
Formulering af fedtopløselig vitamin
CL2015001019S1
(es )
2015-08-28
Ampolleta
DK3129006T3
(da )
2021-04-19
Immunsupprimerende formulering
DK3193840T3
(da )
2021-08-16
Arimoclomol-formulering
DK3233136T3
(da )
2019-05-20
Formulering med målrettede gasfyldte mikrovesikler
FR3039396B1
(fr )
2017-08-11
Base de formulation cosmetique concentree
DK3316856T3
(da )
2021-06-28
Blandede formuleringer
BR112016017925A2
(pt )
2017-08-08
Formulação de colagem estabilizada
DK3173071T3
(da )
2021-06-28
Formularing af maropitant
CL2016002705A1
(es )
2017-06-23
Formulación agroquímica
DK3148513T3
(da )
2020-05-25
Ceritinib-formulering
FI20145118A
(fi )
2015-08-07
Stabiloitu liima-aineformulaatio
FR3021528B1
(fr )
2017-12-08
Formulation cosmetique
MA43166A
(fr )
2018-09-12
Formulation de fviii
DK3193856T3
(da )
2021-09-06
Formulering
DK3212212T3
(da )
2020-12-21
Pulverformulering
TH1601002253A
(th )
2018-06-21
สูตรผสมของอินซูลินกลูไลซีนที่คงตัว
DK3335729T3
(da )
2023-07-10
Etanercept-sammensætning med forbedret stabilitet